Holen Sie sich die Stockscreener-App
0.2101
90.83%
-2.0799
Handel nachbörslich:
.23
0.0199
+9.47%
Acumen Pharmaceuticals Inc Aktie (ABOS) Neueste Nachrichten
Form S-3 Acumen Pharmaceuticals Inc For: 27 October By Investing.com - Investing.com India
Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call Transcript - The Motley Fool
Acumen Pharmaceuticals (ABOS) Climbs 12.15% to $1.99, Pressing Toward $2.09 ResistanceWeak Sell Signals - https://www.dars.gov.et/
A company developing Alzheimer’s treatments will discuss third-quarter results live on Oct. 26. - Stock Titan
Eledon Pharmaceuticals, Inc. (ELDN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Eledon Pharmaceuticals, Inc. (ELDN) stock price, news, quote and history - Yahoo Finance UK
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day - Yahoo Finance
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033 - PR Newswire
Acumen Pharmaceuticals (NASDAQ: ABOS) Aims for Late 2026 Sabirnetug Phase 2 Topline Data - Kalkine Media
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033 - PR Newswire
Form 8K Acumen Pharmaceuticals Inc For: 16 September By Investing.com - Investing.com Nigeria
Form 8K Acumen Pharmaceuticals Inc For: 16 September By Investing.com - Investing.com Canada
Form 8K Acumen Pharmaceuticals Inc For: 16 September By Investing.com - Investing.com UK
BioStem Technologies, Inc. (BSEM) Stock Price & News - Syfe
Acumen will meet investors online Sept. 16 - Stock Titan
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026 - Moomoo
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences - Moomoo
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
An Alzheimer’s drug developer will join two live online events Sept. 9 and 10 - Stock Titan
PLX Stock Price, Quote & News - Syfe
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 - Barchart.com
Acumen Pharmaceuticals Earnings Call: Science vs. Runway - TipRanks
Canadian (CSIQ) Update: Rises 2.31% to $15.08 in the Current Update; Market Levels: the Price Remains Bounded by the Supplied Support and Resistance in the Current UpdateAnalyst Downgrade Signals - www.dars.gov.et
Acumen Pharmaceuticals Inc (ABOS) Stock News Today - TradingKey
Acumen Pharmaceuticals (ABOS) Advances 4.7% to $2.67 as Momentum BuildsForce Index - vinanet.vn
Acumen Pharmaceuticals (ABOS) Advances 4.7% to $2.67 as Momentum BuildsFundamental Weighted - dars.gov.et
Acumen Pharmaceuticals (ABOS) Advances 4.7% to $2.67 as Momentum BuildsDelta Hedging - dars.gov.et
Conferencia de resultados del T2 de 2026 de Acumen Pharmaceuticals (ABOS): lectura de datos de ALTITUDE-AD prevista para finales de 2026 - TradingKey
Acumen Pharmaceuticals (ABOS) Edges Higher: Biotech Stock Gains 1.59% as Bulls Target $2.68 ResistanceCall Wall - vinanet.vn
Citi Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating, Maintains Target Price $4 - moomoo.com
Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat
Acumen Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Acumen Pharmaceuticals Q2 EPS $(0.45) misses $(0.34) estimate - scanx.trade
Acumen Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ABOS) 2026-08-12 - Seeking Alpha
ABOS: Phase II Alzheimer's trial on track for late 2026 readout; strong cash position supports pipeline - TradingView
Acumen Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
Acumen Pharmaceuticals Q2 Earnings Call Highlights - Yahoo Finance
ABOS: Phase II Alzheimer's trial on track for late 2026 readout; strong cash position and pipeline progress - TradingView
Second quarter earnings and operational progress released by Acumen Pharmaceuticals, Inc. - Traders Union
Acumen Pharmaceuticals Reports Q2 Results, Advances Alzheimer’s Programs - TipRanks
Form 8K Acumen Pharmaceuticals Inc For: 12 August By Investing.com - Investing.com Australia
Acumen Pharmaceuticals Q2 2026 Earnings Call Transcript - MarketBeat
Form 8K Acumen Pharmaceuticals Inc For: 12 August By Investing.com - Investing.com India
Form 8K Acumen Pharmaceuticals Inc For: 12 August By Investing.com - Investing.com Canada
Acumen Pharmaceuticals Reports Second-Quarter 2026 Results and Advances Alzheimer’s Pipeline, with ALTITUDE-AD Topline Data Expected in Late 2026 - Quiver Quantitative
Acumen Pharmaceuticals Q2 net loss widens, misses analyst estimates - TradingView
Acumen Reports Q2 Net Loss as Alzheimer’s Trial Readout Nears - Quiver Quantitative
Acumen Pharmaceuticals Reports Second-Quarter 2026 Results and Advances Alzheimer’s Pipeline, with ALTITUDE-AD Topline Data Expected in Late 2026 - Quiver Quantitative
Form 8K Acumen Pharmaceuticals Inc For: 12 August By Investing.com - Investing.com UK
Earnings call transcript: Acumen misses Q2 2026 EPS view as shares slip premarket - Investing.com
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):